Lung function impairment in lung cancer screening: discordance between risk and screening outcomes when looking through a PRISm. | Transl Lung Cancer Res;11(10): 1988-1994, 2022 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Lung function impairment in lung cancer screening: discordance between risk and screening outcomes when looking through a PRISm.

Young, Robert P; Scott, Raewyn J; Gamble, Greg D.

Affiliation

Young RP; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Scott RJ; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Gamble GD; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Transl Lung Cancer Res ; 11(10): 1988-1994, 2022 Oct.

Article in En | MEDLINE | ID: mdl-36386460

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Language: En Journal: Transl Lung Cancer Res Year: 2022 Document type: Article Affiliation country: Nueva Zelanda

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Language: En Journal: Transl Lung Cancer Res Year: 2022 Document type: Article Affiliation country: Nueva Zelanda